A carregar...
Co-Treatment of Hairy Cell Leukemia and Melanoma with the BRAF Inhibitor Dabrafenib
The activating BRAF mutation p.V600E has been identified in many human cancers, including colon and lung adenocarcinoma, papillary thyroid cancer, malignant melanoma, and hairy cell leukemia. The latter two are of particular interest both because of the high proportion of cases harboring the mutatio...
Na minha lista:
| Publicado no: | J Natl Compr Canc Netw |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250239/ https://ncbi.nlm.nih.gov/pubmed/25583765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jnccn.2015.0004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|